S&P 500   3,150.17 (-2.35%)
DOW   27,238.55 (-2.58%)
QQQ   217.31 (-1.84%)
AAPL   290.67 (-2.52%)
FB   198.69 (-1.01%)
MSFT   169.13 (-1.03%)
GOOGL   1,400.87 (-1.34%)
AMZN   1,985.60 (-1.18%)
CGC   19.53 (-3.84%)
BABA   205.62 (-0.26%)
GE   11.32 (-4.56%)
AMD   47.89 (-2.50%)
T   37.58 (-1.24%)
F   7.28 (-3.83%)
PRI   123.12 (-3.03%)
BAC   31.25 (-4.52%)
DIS   128.78 (-3.18%)
GILD   69.59 (-4.54%)
S&P 500   3,150.17 (-2.35%)
DOW   27,238.55 (-2.58%)
QQQ   217.31 (-1.84%)
AAPL   290.67 (-2.52%)
FB   198.69 (-1.01%)
MSFT   169.13 (-1.03%)
GOOGL   1,400.87 (-1.34%)
AMZN   1,985.60 (-1.18%)
CGC   19.53 (-3.84%)
BABA   205.62 (-0.26%)
GE   11.32 (-4.56%)
AMD   47.89 (-2.50%)
T   37.58 (-1.24%)
F   7.28 (-3.83%)
PRI   123.12 (-3.03%)
BAC   31.25 (-4.52%)
DIS   128.78 (-3.18%)
GILD   69.59 (-4.54%)
S&P 500   3,150.17 (-2.35%)
DOW   27,238.55 (-2.58%)
QQQ   217.31 (-1.84%)
AAPL   290.67 (-2.52%)
FB   198.69 (-1.01%)
MSFT   169.13 (-1.03%)
GOOGL   1,400.87 (-1.34%)
AMZN   1,985.60 (-1.18%)
CGC   19.53 (-3.84%)
BABA   205.62 (-0.26%)
GE   11.32 (-4.56%)
AMD   47.89 (-2.50%)
T   37.58 (-1.24%)
F   7.28 (-3.83%)
PRI   123.12 (-3.03%)
BAC   31.25 (-4.52%)
DIS   128.78 (-3.18%)
GILD   69.59 (-4.54%)
S&P 500   3,150.17 (-2.35%)
DOW   27,238.55 (-2.58%)
QQQ   217.31 (-1.84%)
AAPL   290.67 (-2.52%)
FB   198.69 (-1.01%)
MSFT   169.13 (-1.03%)
GOOGL   1,400.87 (-1.34%)
AMZN   1,985.60 (-1.18%)
CGC   19.53 (-3.84%)
BABA   205.62 (-0.26%)
GE   11.32 (-4.56%)
AMD   47.89 (-2.50%)
T   37.58 (-1.24%)
F   7.28 (-3.83%)
PRI   123.12 (-3.03%)
BAC   31.25 (-4.52%)
DIS   128.78 (-3.18%)
GILD   69.59 (-4.54%)
Log in

NYSE:APHA - Aphria Stock Price, Forecast & News

$3.79
-0.13 (-3.32 %)
(As of 02/25/2020 03:02 PM ET)
Today's Range
$3.79
Now: $3.79
$3.97
50-Day Range
$3.92
MA: $4.72
$5.76
52-Week Range
$3.76
Now: $3.79
$10.68
Volume139,702 shs
Average Volume6.73 million shs
Market Capitalization$1.01 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.79
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$179.29 million

Profitability

Miscellaneous

Employees300
Market Cap$1.01 billion
Next Earnings Date4/20/2020 (Estimated)
OptionableNot Optionable

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.


Aphria (NYSE:APHA) Frequently Asked Questions

What is Aphria's stock symbol?

Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."

How were Aphria's earnings last quarter?

Aphria Inc (NYSE:APHA) announced its quarterly earnings results on Tuesday, January, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.02). The company had revenue of $91.38 million for the quarter, compared to analyst estimates of $100.88 million. View Aphria's Earnings History.

When is Aphria's next earnings date?

Aphria is scheduled to release their next quarterly earnings announcement on Monday, April 20th 2020. View Earnings Estimates for Aphria.

What guidance has Aphria issued on next quarter's earnings?

Aphria issued an update on its FY 2020 Pre-Market earnings guidance on Tuesday, January, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $575-625 million.

What price target have analysts set for APHA?

7 brokerages have issued 12-month target prices for Aphria's shares. Their forecasts range from $7.00 to $22.75. On average, they anticipate Aphria's share price to reach $11.74 in the next year. This suggests a possible upside of 208.9% from the stock's current price. View Analyst Price Targets for Aphria.

What is the consensus analysts' recommendation for Aphria?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria.

Has Aphria been receiving favorable news coverage?

News articles about APHA stock have trended very negative this week, according to InfoTrie. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aphria earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Aphria.

Are investors shorting Aphria?

Aphria saw a decline in short interest in January. As of January 15th, there was short interest totalling 30,940,000 shares, a decline of 8.1% from the December 31st total of 33,680,000 shares. Based on an average trading volume of 5,380,000 shares, the days-to-cover ratio is presently 5.8 days. Approximately 13.3% of the company's stock are sold short. View Aphria's Current Options Chain.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), NVIDIA (NVDA), OrganiGram (OGI), HEXO (HEXO), Charlotte's Web (CWBHF), Alibaba Group (BABA) and Advanced Micro Devices (AMD).

Who are Aphria's key executives?

Aphria's management team includes the folowing people:
  • Mr. Carl A. Merton, Chief Financial Officer
  • Ms. Megan McCrae, Director of Marketing
  • Mr. Irwin D. Simon, Interim CEO & Chairman
  • Mr. Jakob Ripshtein, Pres
  • Mr. Gary Leong, Chief Science Officer (Age 54)

Who are Aphria's major shareholders?

Aphria's stock is owned by a number of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.54%), TD Asset Management Inc. (0.29%), Public Sector Pension Investment Board (0.25%), Swiss National Bank (0.18%), AdvisorShares Investments LLC (0.16%) and Bank of America Corp DE (0.14%).

Which major investors are selling Aphria stock?

APHA stock was sold by a variety of institutional investors in the last quarter, including BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Bank of America Corp DE, Goldman Sachs Group Inc., Exane Derivatives, TD Asset Management Inc., Public Sector Pension Investment Board, Actinver Wealth Management Inc. and Belpointe Asset Management LLC.

Which major investors are buying Aphria stock?

APHA stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, AdvisorShares Investments LLC, Virtu Financial LLC, Cambria Investment Management L.P., Oxford Asset Management LLP, Advisor Group Inc., Dubuque Bank & Trust Co. and Credit Suisse AG.

How do I buy shares of Aphria?

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $3.80.

How big of a company is Aphria?

Aphria has a market capitalization of $1.01 billion and generates $179.29 million in revenue each year. Aphria employs 300 workers across the globe.View Additional Information About Aphria.


MarketBeat Community Rating for Aphria (NYSE APHA)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  152 (Vote Outperform)
Underperform Votes:  124 (Vote Underperform)
Total Votes:  276
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APHA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel